Treatment of Barrett's esophagus with high-grade dysplasia

Expert Review of Anticancer Therapy

Volumn 9, Issue 3, 2009, Pages 303-316

  McAllaster, Jennifer D ^a   Buckles, Daniel ^a   Al Kasspooles, Mazin ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Arson plasma coagulation; Barrett's esophagus; Endoscopic mucosal resection; Esophagectomy; High grade dysplasia; Minimally invasive esophagectomy; Photodynamic therapy; Radiofrequency ablation

Indexed keywords

ARGON PLASMA COAGULATION; BARRETT ESOPHAGUS; CANCER GRADING; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS RESECTION; GOLD STANDARD; HUMAN; INTERMETHOD COMPARISON; MINIMALLY INVASIVE SURGERY; PHOTODYNAMIC THERAPY; RADIATION DOSE; RADIOFREQUENCY ABLATION; REVIEW; RISK FACTOR; SAFETY; SURVIVAL RATE; TREATMENT RESPONSE;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CATHETER ABLATION; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOSCOPY; ESOPHAGUS; HUMANS; PHOTOCHEMOTHERAPY; SURVIVAL RATE;

EID: 65749095527     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/14737140.9.3.303     Document Type: Review

References (104)

1. Spechler SJ. Clinical practice. Barrett's Esophagus. N. Engl. J. Med. 346(11), 836-842 (2002).
2. Hameeteman W, Tytgat GN, Houthoff HF et al. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 96(5), 1249-1256 (1989).
3. Skinner DB, Walther BC, Riddell RH et al. Barrett's esophagus. Comparison of benign and malignant cases. Ann. Surg. 198(4), 554-565 (1983).
4. Smith RR, Hamilton SR, Boitnott JK et al. The spectrum of carcinoma arising in Barrett's esophagus. A clinicopathologic study of 26 patients. Am. J. Surg. Pathol. 8(8), 563-573 (1984).
5. Hamilton SR, Smith RR. The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. Am. J. Clin. Pathol. 87(3), 301-312 (1987).
6. Theisen J, Nigro JJ, DeMeester TR. Chronology of the Barrett's metaplasia-dysplasia-carcinoma sequence. Dis. Esophagus 17(1), 67-70 (2004).
7. Levine DS. Management of dysplasia in the columnar-lined esophagus. Gastroenterol. Clin. North Am. 26(3), 613-634 (1997).
8. Thomas T, Richards CJ, de Caestecker JS et al. High-grade dysplasia in Barrett's oesophagus: natural history and review of clinical practice. Aliment. Pharmacol. Ther. 21(6), 747-755 (2005).
9. Haggitt RC. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum. Pathol. 25(10), 982-993 (1994).
10. Sharma P, Falk GW, Weston AP et al. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clin. Gastroenterol. Hepatol. 4(5), 566-572 (2006).
11. Dulai GS, Shekelle PG, Jensen DM et al. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort. Am. J. Gastroenterol. 100(4), 775-783 (2005).
12. Puli S, Rastogi A, Mathur S et al. Development of esophagal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia undergoing surveillance: a meta-analysis and systematic review. Gastrointest. Endosc. 63, AB83 (2006).
13. Reid BJ, Levine DS, Longton G et al. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low and high risk patient subsets. Am. J. Gastroenterol. 95, 1669-1676 (2000).
14. Rice TW, Falk GW, Achkar E et al. Surgical management of high-grade dysplasia in Barrett's esophagus. Am. J. Gastroenterol. 88(11), 1811-1812 (1993).
15. Zaninotto G, Parenti AR, Ruol A et al. Oesophageal resection for high-grade dysplasia in Barrett's oesophagus. Br. J. Surg. 87(8), 1102-1105 (2000).
16. Pera M, Trastek VF, Carpenter HA et al. Barrett's esophagus with high-grade dysplasia: an indication for esophagectomy? Ann. Thorac. Surg. 54(2), 199-204 (1992).
17. Wright TA. High-grade dysplasia in Barrett's oesophagus. Br. J. Surg. 84(6), 760-766 (1997).
18. Al-Kasspooles MF, Hill HC, Nava HR et al. High-grade dysplasia within Barrett's esophagus: controversies regarding clinical opinions and approaches. Ann. Surg. Oncol. 9(3), 222-227 (2002).
19. Reid BJ, Blount PL, Fenz Z et al. Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia. Am. J. Gastroenterol. 95(11), 3089-3096 (2000).
20. Williams VA, Watson TJ, Herbella FA et al. Esophagectomy for high grade dysplasia is safe, curative, and results in good alimentary outcome. J. Gastrointest. Surg. 11(12), 1589-1597 (2007).
21. Reid BJ, Haggitt RC, Rubin CE et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum. Pathol. 19, 166-178 (1988).
22. Montgomery E, Bronner MP, Goldblum JR et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum. Pathol. 32, 368-378 (2001).
23. Downs-Kelly E, Mendelin JE, Benne AE et al. Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsies. Am. J. Gastroenterol. 103(9), 2333-2340 (2008).
24. Moraca RJ, Low DE. Outcomes and health-related quality of life after esophagectomy for high-grade dysplasia and intramucosal cancer. Arch. Surg. 141(6), 545-549 (2006).
25. Schembre DB, Huang JL, Lin OS et al. Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy. Gastrointest. Endosc. 67(4), 595-601 (2008).
26. Streitz JM Jr, Andrews CW Jr, Ellis FH Jr. Endoscopic surveillance of Barrett's esophagus. Does it help? J. Thorac. Cardiovasc. Surg. 105(3), 383-387 (1993).
27. Peters JH, Clark GW, Ireland AP et al. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J. Thorac. Cardiovasc. Surg. 108(5), 813-821 (1994).
28. DeMeester TR, Attwood SE, Smyrk TC et al. Surgical therapy in Barrett's esophagus. Ann. Surg. 212(4), 528-540 (1990).
29. Lerut T, Coosemans W, Van Raemdonck D et al. Surgical treatment of Barrett's carcinoma. Correlations between morphologic findings and prognosis. J. Thorac. Cardiovasc. Surg. 107(4), 1059-1065 (1994).
30. Chang AC, Birkmeyer JD. The volume-performance relationship in esophagectomy. Thorac. Surg. Clin. 16, 87-94 (2006).
31. Swisher SG, Deford L, Merriman KW et al. Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J. Thorac. Cardiovasc. Surg. 119(6), 1126-1132 (2000).
32. Birkmeyer JD, Finlayson EVA, Stukel TA et al. Hospital volume and surgical mortality in the United States. N. Engl. J. Med. 346, 1128-1137 (2002).
33. Dimick JB, Cowan JA, Ailawadi G et al. National variation in operative mortality rates for esophageal resection and the need for quality improvement. Arch. Surg. 138, 1305-1309 (2003).
34. Birkmyer JD, Stukel TA, Siewers AE et al. Surgeon volume and operative mortality in the United States. N. Engl. J. Med. 349, 2117-2127 (2003).
35. Cuschieri A. Endoscopic subtotal oesophagectomy for cancer using the right thoracoscopic approach. Surg. Oncol. 2(Suppl. 1), 3-11 (1993).
36. Qureshi I, Nason KS, Luketich JD. Is minimally invasive esophagectomy indicated for cancer? Expert Rev. Anticancer Ther. 8(9), 1449-1460 (2008).
37. Luketich JD, Alvelo-Rivera M, Buenaventura PO et al. Minimally invasive esophagectomy: outcomes in 222 patients. Ann. Surg. 238(4), 486-494 (2003).
38. Nguyen NT, Hinojosa MW, Smith BR, Chang KJ, Gray J, Hoyt D. Minimally invasive esophagectomy: lessons learned from 104 operations. Ann. Surg. 248(6), 1081-1091 (2008).
39. Nguyen NT, Follette DM, Wolfe BM, Schneider PD, Roberts P, Goodnight JE Jr. Comparison of minimally invasive esophagectomy with transthoracic and transhiatal esophagectomy. Arch. Surg. 135(8), 920-925 (2000).
40. Roorda AK, Marcus SN, Triadafilopoulos G. Early experience with radiofrequency energy ablation therapy for Barrett's esophagus with and without dysplasia. Dis. Esophagus 20(6), 516-522 (2007).
41. Dumoulin FL, Terjung B, Neubrand M, Scheurlen C, Fischer HP, Sauerbruch T. Treatment of Barrett's esophagus by endoscopic argon plasma coagulation. Endoscopy 29, 751-753 (1997).
42. Claydon PE, Ackroyd R. Argon plasma coagulation ablation of Barrett's esophagus. Scand. J. Gastroenterol. 40, 617-628 (2005).
43. Wahab PJ, Mulder CJJ, den Hartog G et al. Argon plasma coagulation in flexible gastrointestinal endoscopy: pilot experiences. Endoscopy 29, 176-187 (1997).
44. Grund KE, Storek D, Farin G. Endoscopic argon plasma coagulation (APC): first clinical experiences in flexible endoscopy. Surg. Endoscopy 2, 42-46 (1994).
45. Morris CD, Byrne JP, Armstrong GR, Attwood SE. Prevention of the neoplastic progression of Barrett's oesphagus by endoscopic argon beam plasma ablation. Br. J. Surg. 88(10), 1357-1362 (2001).
46. Kahaleh M, Van Laethem JL, Nagy N et al. Long-term follow-up and factors predictive of recurrence in Barrett's esophagus treated by argon plasma coagulation and acid suppression. Endoscopy 34, 950-955 (2002).
47. Ferraris R, Fracchia M, Foti M et al. Barrett's oesphagus: long-term follow-up after complete ablation with argon plasma coagulation and the factors that determine its recurrence. Aliment. Pharmacol. Ther. 25(7), 835-840 (2007).
48. Pereira-Lima JC, Busnello JV, Saul C et al. High power setting argon plasma coagulation for the eradication of Barrett's esophagus. Am. J. Gastroenterol. 95, 1661-1668 (2000).
49. Madisch A, Miehlke S, Bayerdorffer E et al. Long-term follow-up after complete ablation of Barrett's esophagus with argon plasma coagulation. World J. Gastroenterol. 11, 1182-1186 (2005).
50. Tigges H, Fuchs KH, Maroske J et al. Comination of endoscopic argon plasma coagulation and antireflux surgery for treatment of Barrett's esophagus. J. Gastrointest. Surg. 5, 251-259 (2001).
51. Dumoulin FL, Terjung B, Neubrand M et al. Treatment of Barrett's esophagus by endoscopic argon plasma coagulation. Endoscopy 29, 751-753 (1997).
52. Van Laethem JL, Cremer M, Peny MO et al. Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and mid term results. Gut 43(6), 747-751 (1998).
53. Manner H, May A, Miehlke S et al. Ablation of nonneoplastic Barrett's mucosa using argon plasma coagulation with concomitant esomeprazole therapy (APBANEX): a prospective multicenter evaluation. Am. J. Gastroenterol. 101(8), 1762-1769 (2006).
54. Ackroyd R, Tam W, Schoeman M et al. Prospective randomized controlled trial of argon plasma coagulation ablation vs. endoscopic surveillance of patients with Barrett's esophagus with antireflux surgery. Gastrointest. Endosc. 59(1), 1-7 (2004).
55. Bright T, Watson DI, Tam W et al. Randomized trial of argon plasma coagulation versus endoscopic surveillance for Barrett esophagus after antireflux surgery: late results. Ann. Surg. 246(6), 1016-1020 (2007).
56. Attwood SE, Lewis CJ, Caplin S, Hemming K, Armstrong G. Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus. Clin. Gastroenterol. Hepatol. 1(4), 258-263 (2003).
57. Byrne JP, Armstrong GR, Attwood SE. Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulation. Am. J. Gastroenterol. 93, 1810-1815 (1998).
58. Morris CD, Byrne JP, Armstrong GR et al. Prevention of the neoplastic progression of Barrett's esophagus by endoscopic argon beam plasma ablation. Br. J. Surg. 88, 1357-1362 (2001).
59. Van Laethem JL, Jagodzinski R, Peny MO et al. Argon plasma coagulation in the treatment of Barrett's high-grade dysplasia and in situ adenocarcinoma. Endoscopy 33, 257-261 (2001).
60. Van Laetham JL, Peny MO, Salmon I et al. Intramucosal adenocarcinoma arising under squamous reepithelialisation of Barrett's oesophagus. Gut 46, 574-577 (2000).
61. Petersen BT, Chuttani R, Croffie J et al. Photodynamic therapy for gastrointestinal disease. Gastrointest. Endosc. 63(7), 927-932 (2006).
62. Wolfsen HC. Present status of photodynamic therapy for high-grade dysplasia in Barrett's esophagus. J. Clin. Gastroenterol. 39(3), 189-202 (2005).
63. Schuchert MJ, Luketich JD. Barrett's esophagus - emerging concepts and controversies. J. Surg. Oncol. 95(3), 185-189 (2007).
64. Petersen BT, Chuttani R, Croffie J et al. Photodynamic therapy for gastrointestinal disease. Gastrointest. Endosc. 63(7), 927-932 (2006).
65. Overholt B, Panjehpour M, Tefftellar E et al. Photodynamic therapy for treatment of early adenocarcinoma in Barrett's esophagus. Gastrointest. Endosc. 39(1), 73-76 (1993).
66. Overholt BF, Panjehpour M, Haydek JM. Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointest. Endosc. 49(1), 107 (1999).
67. Panjehpour M, Overholt BF, Haydek JM et al. Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett's esophagus and effect of oral steroids on stricture formation. Am. J. Gastroenterol. 95(9), 2177-2184 (2000).
68. Wolfsen HC, Hemminger LL, Wallace MB et al. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer. Aliment. Pharmacol. Ther. 20(10), 1125-1131 (2004).
69. Overholt BF, Wang KK, Burdick JS et al. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. Gastrointest. Endosc. 66(3), 460-468 (2007).
70. Ragunath K, Krasner N, Raman VS et al. Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness. Scand. J. Gastroenterol. 40(7), 750-758 (2005).
71. Li YM, Li L, Yu CH et al. A systematic review and meta-analysis of the treatment for Barrett's esophagus. Dig. Dis. Sci. 53(11), 2837-2846 (2008).
72. Hernandez JC, Reicher S, Chung D et al. Pilot series of radiofrequency ablation of Barrett's esophagus with or without dysplasia. Endoscopy 40(5), 388-392 (2008).
73. Ganz RA, Utley DS, Stern R et al. Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: a phased evaluation in the porcine and in human esophagus. Gastrointest. Endosc. 60, 1002-1010 (2004).
74. Ganz RA, Batts K. Pilot human study of a balloon-based electrode for ablation of esophageal epithelium: results in subjects prior to planned esophagectomy. Gastrointest. Endosc. 59, AB252 (2004).
75. Dunkin BJ, Martinez J, Bejarano PA et al. Thin-layer ablation of human esophageal epithelium using bipolar radiofrequency balloon device. Surg. Endosc. 20(1), 125-130 (2006).
76. Sharma VK, Overholt B, Wang K et al. A randomized, multi-center evaluation of ablation of nondysplastic short segment Barrett esophagus using BARRX bipolar balloon device: extended follow-up of Ablation of Intestinal metaplasia (AIM-I) Trial. Gastrointest. Endosc. 61, T1391 (2005).
77. Fleischer DE, Overholt BF, Sharma VK et al. Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up. Gastrointest. Endosc. 68(5), 867-876 (2008).
78. Shaheen NJ, Sharma P, Overholt BF et al. A randomized, multicenter, shamcontrolled trial of radiofrequency ablation (RFA) for subjects with Barrett's esophagus (BE) containing dysplasia: interim results of the AIM dysplasia trial [abstract]. Gastroenterology. 134, A-A37 (2008).
79. Pouw RE, Sharma VK, Bergman JJ, Fleischer DE. Radiofrequency ablation for total Barrett's eradication: a description of the endoscopic technique, its clinical results and future prospects. Endoscopy 40, 1033-1040 (2008).
80. Ganz RA, Overholt BF, Sharma VK et al. Circumferential ablation of Barret's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry. Gastrointest. Endosc. 68(1), 35-40 (2008).
81. Gondrie JJ, Pouw RE, Sondermeijer CMT et al. Step-wise circumferential and focal ablation of Barrett's esophagus with high-grade dysplasia: results of the first prospective series of 11 patients. Endoscopy 40, 359-369 (2008).
82. Gondrie JJ, Pouw RE, Sondermeijer CM et al. Effective treatment of early Barrett's neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy 40(5), 370-379 (2008).
83. Ahmadi A, Draganov P. Endoscopic mucosal resection in the upper gastrointestinal tract. World J. Gastroenterol. 14(13), 1984-1989 (2008).
84. Rosenberg N. Submucosal saline wheal as safety factor in fulguration of rectal and sigmoid polypi. AMA Arch. Surg. 70(1), 120-122 (1955).
85. Soetikno R, Kaltenback T, Yeh R et al. Endoscopic mucosal resection for early cancers of the upper gastrointestinal tract. J. Clin. Oncol. 23(20), 4490-4498 (2005).
86. Seewald S, Ang TL, Soehendra N. Endoscopic mucosal resection of Barrett's oesophagus containing dysplasia or intramucosal cancer. Postgrad. Med. J. 83(980), 367-372 (2007).
87. Faruqi SA, Arantes V, Bhutani MS. Barrett's esophagus: current and future role of endosonography and optical coherence tomography. Dis. Esophagus 17(2), 118-123 (2004).
88. Stein HJ, Feith M, Mueller J et al. Limited resection for early adenocarcinoma in Barrett's esophagus. Ann. Surg. 232(6), 733-742 (2000).
89. Nigro JJ, Hagen JA, DeMeester TR et al. Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy. J. Thorac. Cardiovasc. Surg. 117(1), 16-23 (1999).
90. Ell C, May A, Gossner L et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 118(4), 670-677 (2000).
91. Ell C, May A, Pech O et al. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). Gastrointest. Endosc. 65(1), 3-10 (2007).
92. Lopes CV, Hela M, Pesenti C. Circumferential endoscopic resection of Barrett's esophagus with high-grade dysplasia or early adenocarcinoma. Surg. Endosc. 21(5), 820-824 (2007).
93. Peters FP, Kara MA, Rosmolen WD et al. Stepwise radical endoscopic resection is effective for complete removal of Barrett's esophagus with early neoplasia: a prospective study. Am. J. Gastroenterol. 101(7), 1449-1457 (2006).
94. Nijhawan PK, Wang KK. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett's esophagus. Gastrointest. Endosc. 52(3), 328-332 (2000).
95. Buttar NS, Wang KK, Lutzke LS et al. Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett's esophagus. Gastrointest. Endosc. 54, 682-688 (2001).
96. May A, Gossner L, Pech O et al. Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett's esophagus (SSBE): curative treatment using local endoscopic treatment techniques. Endoscopy 34, 604-610 (2002).
97. May A, Gossner L, Pech O et al. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach. Eur. J. Gastroenterol. Hepatol. 14, 1085-1091 (2002).
98. Peters FP, Kara MA, Rosmolen WD et al. Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett's esophagus. Gastrointest. Endosc. 61(4), 506-514 (2005).
99. Pacifico RJ, Wang KK, Wongkeesong L et al. Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus. Clin. Gastroenterol. Hepatol. 1, 252-257 (2003).
100. Seewald S, Akaraviputh T, Seitz U et al. Circumferential EMR and complete removal of Barrett's epithelium: a new approach to management of Barrett's esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma. Gastrointest. Endosc. 57(7), 854-859 (2003).
101. Giovannini M, Bories E, Pesenti C et al. Circumferential endoscopic mucosal resection in Barrett's esophagus with high-grade intraepithelial neoplasia or mucosal cancer. Preliminary results in 21 patients. Endoscopy 36(9), 782-787 (2004).
102. Larghi A, Lightdale CJ, Ross AS. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma. Endoscopy 39(12), 1086-1091 (2007).
103. Overholt BF, Panjehpour M, Halberg DL. Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results. Gastrointest. Endosc. 58(2), 183-188 (2003).
104. Sharma VK, Wang KK, Overholt BF et al. Balloon-based, circumferential, endoscopic radiofrequency ablatikon of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointest. Endosc. 65, 185-195 (2007).